lp the world's biopharmaceutical
companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions --
North America, Europe, Asia/Pacific, Latin America and Africa -- to meet
customer needs. We have conducted clinical trials and provided regulatory
and pharmacovigilance services in more than 80 countries. Kendle was named
"Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S.
investigative sites and "Best CRO" for 2007 and 2006 by leading global
pharmaceutical publication Scrip.
Additional information and investor kits are available upon request
from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the
Company's Web site at http://www.kendle.com.
'/>"/>SOURCE Kendle International Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality2.
Kendle to Present at the Wachovia 2008 Healthcare Conference3.
Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant4.
Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip5.
Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast6.
Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference7.
Kendle to Present at the UBS Global Life Sciences Conference8.
Kendle to Present at Bear Stearns 20th Annual Healthcare Conference9.
Kendle to Present at Thomas Weisel Partners Healthcare Conference 200710.
Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event11.
Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22